Tanya Fischer

1.9k total citations
32 papers, 1.3k citations indexed

About

Tanya Fischer is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Tanya Fischer has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 11 papers in Neurology and 10 papers in Molecular Biology. Recurrent topics in Tanya Fischer's work include Pain Mechanisms and Treatments (11 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Lysosomal Storage Disorders Research (6 papers). Tanya Fischer is often cited by papers focused on Pain Mechanisms and Treatments (11 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Lysosomal Storage Disorders Research (6 papers). Tanya Fischer collaborates with scholars based in United States, United Kingdom and Germany. Tanya Fischer's co-authors include Stephen G. Waxman, Yangzhou Du, Cheryl F. Dreyfus, George Manos, David W. Dodick, Ronald N. Marcus, David Stock, Peter J. Goadsby, Sulayman D. Dib‐Hajj and Andrew M. Tan and has published in prestigious journals such as Journal of Neuroscience, Blood and Neurology.

In The Last Decade

Tanya Fischer

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanya Fischer United States 16 634 478 431 250 237 32 1.3k
Nobuo Araki Japan 19 335 0.5× 409 0.9× 321 0.7× 175 0.7× 186 0.8× 89 1.3k
Andrew Moss United Kingdom 19 911 1.4× 384 0.8× 645 1.5× 97 0.4× 181 0.8× 22 1.6k
Britto P. Nathan United States 19 1.0k 1.6× 761 1.6× 486 1.1× 179 0.7× 160 0.7× 32 2.0k
C. Verrecchia France 14 494 0.8× 380 0.8× 527 1.2× 141 0.6× 231 1.0× 25 1.2k
Rou‐Gang Xie China 23 903 1.4× 597 1.2× 604 1.4× 111 0.4× 125 0.5× 49 1.7k
Dimitrios Papadopoulos Greece 16 303 0.5× 336 0.7× 150 0.3× 145 0.6× 178 0.8× 42 1.4k
Ruoyan Chen United States 16 174 0.3× 245 0.5× 706 1.6× 283 1.1× 74 0.3× 28 1.6k
Sara Ebrahimi Nasrabady Iran 11 261 0.4× 332 0.7× 242 0.6× 112 0.4× 245 1.0× 13 1.0k
Yanlei Hao China 18 281 0.4× 604 1.3× 295 0.7× 165 0.7× 206 0.9× 44 1.3k
Yumiko Motoi Japan 26 625 1.0× 451 0.9× 381 0.9× 119 0.5× 762 3.2× 76 1.9k

Countries citing papers authored by Tanya Fischer

Since Specialization
Citations

This map shows the geographic impact of Tanya Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya Fischer more than expected).

Fields of papers citing papers by Tanya Fischer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya Fischer. The network helps show where Tanya Fischer may publish in the future.

Co-authorship network of co-authors of Tanya Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya Fischer. A scholar is included among the top collaborators of Tanya Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya Fischer. Tanya Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaodong, Richard Kirk, Mark Matijevic, et al.. (2024). Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers. Advances in Therapy. 42(2). 813–829. 1 indexed citations
2.
Fattizzo, Bruno, Gillian Evans, Audrey G. Wells, et al.. (2024). Evaluation of Obexelimab in Patients with Warm Autoimmune Hemolytic Anemia: Preliminary Results from an Open Label Phase 2 Study. Blood. 144(Supplement 1). 5212–5212. 1 indexed citations
3.
Yuan, William, Brett K. Beaulieu‐Jones, Richard C. Krolewski, et al.. (2021). Accelerating diagnosis of Parkinson’s disease through risk prediction. BMC Neurology. 21(1). 201–201. 18 indexed citations
4.
Pulikottil-Jacob, Ruth, et al.. (2020). Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases. Orphanet Journal of Rare Diseases. 15(1). 92–92. 6 indexed citations
5.
Bonner, Nicola, et al.. (2020). Patients’ experiences of Parkinson’s disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson’s disease. Journal of Patient-Reported Outcomes. 4(1). 65–65. 12 indexed citations
6.
Fischer, Tanya, Thomas Gasser, Stuart Isaacson, et al.. (2019). Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson’s disease patients with a GBA mutation (S4.002). Neurology. 92(15_supplement). 3 indexed citations
7.
Peterschmitt, Michel, Thomas Gasser, Stuart Isaacson, et al.. (2019). Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation. Molecular Genetics and Metabolism. 126(2). S117–S117. 15 indexed citations
8.
Puga, Ana Cristina, Alaa Hamed, Pascal Minini, et al.. (2018). Functional performance in late-onset GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), longitudinal data over 3 consecutive years. Molecular Genetics and Metabolism. 123(2). S122–S122. 1 indexed citations
9.
10.
11.
Marcus, Ronald N., Peter J. Goadsby, David W. Dodick, et al.. (2013). BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia. 34(2). 114–125. 225 indexed citations
12.
Bakkers, Mayienne, Catharina G. Faber, Jos P. H. Reulen, et al.. (2013). Temperature threshold testing: a systematic review. Journal of the Peripheral Nervous System. 18(1). 7–18. 37 indexed citations
13.
Tan, Andrew M., Omar Abdel Samad, Tanya Fischer, et al.. (2012). Maladaptive Dendritic Spine Remodeling Contributes to Diabetic Neuropathic Pain. Journal of Neuroscience. 32(20). 6795–6807. 95 indexed citations
14.
Fischer, Tanya & Stephen G. Waxman. (2010). Neuropathic pain in diabetes—evidence for a central mechanism. Nature Reviews Neurology. 6(8). 462–466. 78 indexed citations
15.
Fischer, Tanya & Stephen G. Waxman. (2009). Familial pain syndromes from mutations of the Nav1.7 sodium channel. Annals of the New York Academy of Sciences. 1184(1). 196–207. 63 indexed citations
16.
Dib‐Hajj, Sulayman D., Mark Estación, Brian W. Jarecki, et al.. (2008). Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Publisher. 14 indexed citations
17.
Veer, Ashlee Van’t, et al.. (2008). Brain‐derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway. Journal of Neuroscience Research. 87(1). 69–78. 105 indexed citations
18.
Bostock, Hugh, Sulayman D. Dib‐Hajj, Tanya Fischer, et al.. (2007). 293 SPONTANEOUS IMPULSE GENERATION IN C‐NOCICEPTORS OF FAMILIAL ERYTHROMELALGIA (FE) PATIENTS. European Journal of Pain. 11(S1).
19.
Du, Yangzhou, et al.. (2005). Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. Molecular and Cellular Neuroscience. 31(2). 366–375. 47 indexed citations
20.
Du, Yangzhou, et al.. (2003). Regionally Specific Effects of BDNF on Oligodendrocytes. Developmental Neuroscience. 25(2-4). 116–126. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuo Araki Breakdown of academic impact, for papers by Andrew Moss Breakdown of academic impact, for papers by Britto P. Nathan Breakdown of academic impact, for papers by C. Verrecchia Breakdown of academic impact, for papers by Rou‐Gang Xie Breakdown of academic impact, for papers by Dimitrios Papadopoulos Breakdown of academic impact, for papers by Ruoyan Chen Breakdown of academic impact, for papers by Sara Ebrahimi Nasrabady Breakdown of academic impact, for papers by Yanlei Hao Breakdown of academic impact, for papers by Yumiko Motoi
Rankless by CCL
2026